Outlook Therapeutics, Inc. (OTLK) Debt to Equity Ratio
Outlook Therapeutics, Inc. (OTLK) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2020-09-30 | 1.63 |
| 2021-09-30 | 2.57 |
| 2022-09-30 | 1.25 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Outlook Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("OTLK", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | OTLK | $0.61 | -5.90% | 14.64M |
| 3 | ||||
| 4 | ||||
| 5 |